Nan Fung Life Sciences, part of Nan Fung Group, is a global investment platform focusing on life sciences. Leveraging on Nan Fung Group’s strong capital base and long-term commitment to the area, the company is aimed to become the ideal partner for scientists, entrepreneurs, corporations and investors in the life science space. Through direct investments via Pivotal BioVenture Partners funds (both in the US and China) and fund investments covering full spectrum of the industry (including therapeutics, medical devices and diagnostics) and across different development stages, Nan Fung Life Sciences has significant presence in both the US and Greater China.
Pivotal bioVenture Partners China, a member of Nan Fung Life Sciences, is a venture capital firm specializing in venture building in the life sciences industry. Its investment strategy is centered on identifying promising innovative products and technologies and bringing them to serve the growing unmet medical needs in Greater China region by building new ventures. Its investment areas include therapeutics, medical devices and medical services. The Pivotal China team includes experienced life science investors and entrepreneurs with successful track records of venture building and investing.
Morningside Ventures was founded in 1986 by the Chan family of Hong Kong. Since its establishment, Morningside has been focusing on trends at the forefront of the life science and healthcare industries globally, expanding its business scope and investment footprint over North America, Europe, and Greater China.
Loyal Valley Capital, founded in 2015, is a thematic, research-oriented private equity firm that has been a “partner of choice” for China’s most promising companies. Loyal Valley Capital has been involved in the funding of leading players such as TikTok, Didi Chuxing, Bilibili, Junshi Biosciences, InnoCare Pharma, Akesobio, POP MART and SUPCON.
Founded in 2019, Octagon Capital Advisors LP is a multi-stage investment manager dedicated to evidence-based investing in both public and private healthcare companies, specifically in the United States and China. Octagon Capital focuses on strategic long-term investments and strive to work with our portfolio management teams as partners. Octagon Capital manages capital on behalf of global institutions such as university endowments, non-profit foundations, family offices, pension funds and established asset managers.
Dr. Adrian Cheng, pillar of the New World Development and the Chow Tai Fook, and Founder of K11, is a renowned entrepreneur and businessman that has been focused on medical and healthcare sector. He’s invested in multiple well-established biopharmaceutical enterprises, such as Alphamab Oncology, Athenex, 3D Medicines, Transcenta, Cothera etc., as well as medical organizations devoted to developing innovative and quality services, such as WeDoctor and Sanbo Brain Hospital.
To report a potential adverse event, please refer to the contact information below:
Mainland China: firstname.lastname@example.org
Hong Kong, China: email@example.com